Tiago Lopes: Can AI Predict Immune Reactions of New Drugs? Yes!
Tiago Lopes, Research Scientist at Heidelberg University, shared on LinkedIn:
”Can AI predict immune reactions of new drugs? Yes.
Its not perfect, but it is very good.
In this paper fresh from the oven, my colleagues from Japan and I present a new coagulation factor 8 (FVIII), designed and tested as a gene therapy.
People who have a defect in this gene live with hemophilia, a coagulation problem that requires constant injections; and even then, they are at constant risk of joint, muscle and other hemorrhages.
The treatment is super expensive, and still has a major problem of triggering an immune reaction; it renders the treatment ineffective, which without a doubt, sucks.
Here, a comprehensive and reliable AI prediction was made, showing this FVIII variant is not worse than the “original” protein that people have.
Hope. This is the word for patients and their families.
We are working around the clock to have your kids playing soccer without worrying about not walking the next day.”

Stay updated with Hemostasis Today.
-
Feb 3, 2026, 09:51Rucha Patil Reflects on 49th MHG Annual Conference and Essence of ASH 2025
-
Feb 3, 2026, 09:37Grigoris Gerotziafas on VTE in MM and BCMA: We Are Pleased to Announce Our New Systematic Review
-
Feb 3, 2026, 09:24Early-Bird Registration for the WFH 2026 World Congress is Now Open
-
Feb 3, 2026, 09:15Joshua Bernstock: Prehospital Stroke Triage Has Hit a Ceiling
-
Feb 3, 2026, 09:00A Major Highlight of 2025 and Honour For Me: Ashkan Shoamanesh at Huashan International Stroke Conference
-
Feb 3, 2026, 05:58Rainer Kaiser: The Role of Procoagulant Platelets in Cardiovascular Disease and Thromboinflammation
-
Feb 2, 2026, 17:54Danny Gaskin: Nominations are Open for the BBTS Transfusion Practitioner Special Interest Group Award 2026
-
Feb 2, 2026, 17:44Important Webinar on Care for Patients with iTTP – ISTH
-
Feb 2, 2026, 17:21Tagreed Alkaltham: Some Risks Don’t Look Like Risks in Healthcare